Aytu Biopharma (AYTU) Other Accumulated Expenses (2019 - 2026)
Aytu Biopharma (AYTU) posted quarterly Other Accumulated Expenses of $2.2 million for Q1 2026, up 18.99% year-over-year from $1.8 million in Q1 2025, and down 24.77% quarter-over-quarter from $2.9 million in Q4 2025.
Aytu Biopharma (AYTU) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Other Accumulated Expenses for 8 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 18.99% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 18.99% YoY), while the FY2025 annual figure was $1.9 million, down 78.86% from the prior year.
- Other Accumulated Expenses retreated to $2.2 million in Q1 2026 per AYTU's latest filing, from $2.9 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $9.1 million in Q1 2024 and bottomed at $1.8 million in Q1 2025.
- Historically, Other Accumulated Expenses has averaged $4.9 million across 5 years, with a median of $3.5 million in 2022.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses surged 214.18% — and 2025, when it tumbled 79.79%.
- Aytu Biopharma's Other Accumulated Expenses stood at $7.8 million in 2022, then plunged by 67.7% to $2.5 million in 2023, then soared by 180.95% to $7.1 million in 2024, then tumbled by 58.88% to $2.9 million in 2025, then fell by 24.77% to $2.2 million in 2026.
- Business Quant data shows AYTU's Other Accumulated Expenses at $2.2 million in Q1 2026, $2.9 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 8.96 Mn |
| Mar 31, 2024 | 9.15 Mn |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 2.51 Mn |
| Jun 30, 2023 | 7.09 Mn |
| Mar 31, 2023 | 7.45 Mn |
| Dec 31, 2022 | 7.83 Mn |
| Sep 30, 2022 | 3.21 Mn |
| Jun 30, 2022 | 5.36 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.17 Mn |
| Sep 30, 2021 | 3.19 Mn |
| Jun 30, 2021 | 8.35 Mn |